China NT Pharma's (HKG:1011) CEO Zhang Bozhi stepped down to devote more time to his personal and other affairs effective July 3, according to a same-day Hong Kong bourse filing.
Shares of the healthcare marketing company were up over 1% in Monday afternoon trading.
The company named NG, Andy Ching Kit, as its new CEO effective the same day. NG joined the company in 2018 and has held various positions including international business manager and general manager.